Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer - PubMed (original) (raw)
Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer
Chong-Jen Yu et al. Lung Cancer. 2005 Jan.
Abstract
Sialyl Lewis antigens (sLe(x/a)) are cancer-associated carbohydrate determinants, serve as ligands of the selectin family and are associated with hematogenous metastasis of cancer. So far, the clinicopathologic values of sialyl Lewis x (sLe(x)) and sialyl Lewis a (sLe(a)) in lung cancer have remained controversial. Using immunohistochemistry, the expressions of sLe(x) and sLe(a) antigens, and an airway mucin (MUC5AC) protein, which was supposed to be the major carrying protein of sialyl Lewis moieties, were studied in surgically resected tumor tissues of 61 patients with stages I or II NSCLC. Thirty-two (52.5%) of the 61 studied subjects were found to be positive for expression of sLe(a), 40 (65.6%) were positive for expression of sLe(x), and 16 (26.2%) were positive for MUC5AC protein. Both the expression of sLe(x) and MUC5AC were associated with adenocarcinoma subtype. Patients bearing tumors with MUC5AC and/or sLe(x) expression had a higher probability of post-operative distant metastasis. Survival analysis demonstrated that patients bearing tumors with expression of sLe(x) antigen or MUC5AC had shorter overall survival. The multivariate logistic regression showed that age >65 years old (OR = 0.207, 95% CI = 0.075-0.569, P = 0.002), nodal status (OR = 6.575, 95% CI = 2.459-17.583, P < 0.001), and MUC5AC (OR = 5.545, 95% CI = 1.998-15.386, P = 0.001) were independent factors affecting survival. We concluded that the expression of sLe(x) was related to MUC5AC protein, while patients with tumors co-expressing both MUC5AC and sLe(x) antigen had the worst survival.
Similar articles
- Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S. Satoh H, et al. Clin Cancer Res. 1997 Apr;3(4):495-9. Clin Cancer Res. 1997. PMID: 9815711 - Expressions of Lewis antigens in human non-small cell pulmonary cancer and primary liver cancer with different pathological conditions.
Wang QY, Wu SL, Chen JH, Liu F, Chen HL. Wang QY, et al. J Exp Clin Cancer Res. 2003 Sep;22(3):431-40. J Exp Clin Cancer Res. 2003. PMID: 14582703 - Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients.
Saito K, Fujii Y, Kawakami S, Hayashi T, Arisawa C, Koga F, Kageyama Y, Kihara K. Saito K, et al. Anticancer Res. 2003 Jul-Aug;23(4):3441-6. Anticancer Res. 2003. PMID: 12926087 - [Clinical value of carbohydrate antigens, sialyl Lewis-x and sialyl Lewis-a in gastrointestinal cancer].
Nakamori S, Arai I, Okamura S, Imaoka S, Furukawa H, Kabuto T, Ishikawa O, Sasaki Y, Kameyama M, Iwanaga T. Nakamori S, et al. Nihon Geka Gakkai Zasshi. 1996 Feb;97(2):165-71. Nihon Geka Gakkai Zasshi. 1996. PMID: 8632746 Review. Japanese. - [Immunohistochemical expression of sialyl-Lewis antigens in lung cancer].
Yamanda T, Haniuda M, Iida F, Kannagi R. Yamanda T, et al. Nihon Rinsho. 1995 Jul;53(7):1776-80. Nihon Rinsho. 1995. PMID: 7630018 Review. Japanese.
Cited by
- The Role of Aquaporin 5 (AQP5) in Lung Adenocarcinoma: A Review Article.
Jaskiewicz L, Romaszko-Wojtowicz A, Doboszynska A, Skowronska A. Jaskiewicz L, et al. Cells. 2023 Jan 31;12(3):468. doi: 10.3390/cells12030468. Cells. 2023. PMID: 36766810 Free PMC article. Review. - Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.
Dwertmann Rico S, Büscheck F, Dum D, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Perez D, Izbicki JR, Neipp M, Mofid H, Daniels T, Isbert C, Fraune C, Möller K, Menz A, Bernreuther C, Lebok P, Clauditz T, Sauter G, Uhlig R, Wilczak W, Simon R, Steurer S, Burandt E, Marx A, Krech T. Dwertmann Rico S, et al. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221106504. doi: 10.1177/03946320221106504. Int J Immunopathol Pharmacol. 2022. PMID: 35764407 Free PMC article. - MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
Rico SD, Mahnken M, Büscheck F, Dum D, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Möller-Koop C, Fraune C, Möller K, Menz A, Bernreuther C, Jacobsen F, Lebok P, Clauditz TS, Sauter G, Uhlig R, Wilczak W, Simon R, Steurer S, Minner S, Burandt E, Krech T, Marx AH. Rico SD, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211043328. doi: 10.1177/15330338211043328. Technol Cancer Res Treat. 2021. PMID: 34547930 Free PMC article. - MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.
Sun Y, Sun X, You C, Ma S, Luo Y, Peng S, Tang F, Tian X, Wang F, Huang Z, Yu H, Xiao Y, Wang X, Zhang J, Gong Y, Xie C. Sun Y, et al. Int J Biol Sci. 2021 Jun 16;17(10):2523-2536. doi: 10.7150/ijbs.59430. eCollection 2021. Int J Biol Sci. 2021. PMID: 34326691 Free PMC article. - Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy.
Matveeva OV, Shabalina SA. Matveeva OV, et al. Cancers (Basel). 2020 Dec 5;12(12):3659. doi: 10.3390/cancers12123659. Cancers (Basel). 2020. PMID: 33291506 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical